Statement by Vicki Saporta, President and CEO of the National Abortion Federation (NAF), on the New FDA Label for Medical Abortion Pill, Mifeprex: We are delighted that the FDA has approved a label change, which brings the label for mifepristone in-line with scientific research and evidence-based practice. Since mifepristone was initially approved by the FDA … Continue reading New FDA label for medical abortion pill, Mifeprex